Regentis Biomaterials LTD Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
AMEX
Rosalind Advisors Inc. and its affiliated entities have reported beneficial ownership of 9.9% of Regentis Biomaterials Ltd.'s common shares, primarily through warrants and existing shares.